Bifogade filer
Kurs
-5,95%
Likviditet
0,06 MSEK
Kalender
Est. tid* | ||
2025-05-21 | N/A | X-dag ordinarie utdelning SYNT 0.00 SEK |
2025-05-20 | N/A | Årsstämma |
2025-05-20 | 08:40 | Kvartalsrapport 2025-Q1 |
2025-02-25 | - | Bokslutskommuniké 2024 |
2024-12-17 | - | Extra Bolagsstämma 2024 |
2024-11-19 | - | Kvartalsrapport 2024-Q3 |
2024-08-27 | - | Kvartalsrapport 2024-Q2 |
2024-05-22 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
2024-05-21 | - | Årsstämma |
2024-05-21 | - | Kvartalsrapport 2024-Q1 |
2024-02-20 | - | Bokslutskommuniké 2023 |
2023-11-10 | - | Kvartalsrapport 2023-Q3 |
2023-08-22 | - | Kvartalsrapport 2023-Q2 |
2023-05-24 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
2023-05-23 | - | Årsstämma |
2023-05-23 | - | Kvartalsrapport 2023-Q1 |
2023-02-15 | - | Bokslutskommuniké 2022 |
2022-11-16 | - | Kvartalsrapport 2022-Q3 |
2022-08-23 | - | Kvartalsrapport 2022-Q2 |
2022-05-11 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
2022-05-10 | - | Årsstämma |
2022-05-10 | - | Kvartalsrapport 2022-Q1 |
2022-03-29 | - | Extra Bolagsstämma 2022 |
2022-02-22 | - | Bokslutskommuniké 2021 |
2021-11-11 | - | Kvartalsrapport 2021-Q3 |
2021-07-13 | - | Kvartalsrapport 2021-Q2 |
2021-05-20 | - | Split SYNT 1:10 |
2021-05-12 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
2021-05-11 | - | Årsstämma |
2021-05-11 | - | Kvartalsrapport 2021-Q1 |
2021-02-18 | - | Bokslutskommuniké 2020 |
2020-11-12 | - | Kvartalsrapport 2020-Q3 |
2020-10-02 | - | X-dag ordinarie utdelning SYNT 1.50 SEK |
2020-07-14 | - | Kvartalsrapport 2020-Q2 |
2020-05-05 | - | Årsstämma |
2020-05-05 | - | Kvartalsrapport 2020-Q1 |
2020-02-27 | - | Bokslutskommuniké 2019 |
2019-11-12 | - | Kvartalsrapport 2019-Q3 |
2019-07-14 | - | Kvartalsrapport 2019-Q2 |
2019-04-30 | - | X-dag ordinarie utdelning SYNT 1.50 SEK |
2019-04-29 | - | Årsstämma |
2019-04-29 | - | Kvartalsrapport 2019-Q1 |
2019-02-27 | - | Bokslutskommuniké 2018 |
2018-11-16 | - | Kvartalsrapport 2018-Q3 |
2018-08-22 | - | Kvartalsrapport 2018-Q2 |
2018-04-26 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
2018-04-25 | - | Årsstämma |
2018-04-25 | - | Kvartalsrapport 2018-Q1 |
2018-02-21 | - | Bokslutskommuniké 2017 |
2017-11-10 | - | Kvartalsrapport 2017-Q3 |
2017-08-24 | - | Kvartalsrapport 2017-Q2 |
2017-04-26 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
2017-04-25 | - | Årsstämma |
2017-04-25 | - | Kvartalsrapport 2017-Q1 |
2017-02-15 | - | Bokslutskommuniké 2016 |
2016-10-28 | - | Kvartalsrapport 2016-Q3 |
2016-08-26 | - | Kvartalsrapport 2016-Q2 |
2016-04-27 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
2016-04-26 | - | Årsstämma |
2016-04-26 | - | Kvartalsrapport 2016-Q1 |
2016-02-26 | - | Bokslutskommuniké 2015 |
2015-10-30 | - | Kvartalsrapport 2015-Q3 |
2015-08-28 | - | Kvartalsrapport 2015-Q2 |
2015-04-13 | - | Årsstämma |
2015-04-13 | - | Kvartalsrapport 2015-Q1 |
2015-02-17 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
2015-02-13 | - | Bokslutskommuniké 2014 |
2014-11-28 | - | Kvartalsrapport 2014-Q3 |
2014-09-26 | - | Extra Bolagsstämma 2014 |
2014-08-29 | - | Kvartalsrapport 2014-Q2 |
Beskrivning
Land | Sverige |
---|---|
Lista | Spotlight |
Sektor | Hälsovård |
Industri | Medicinteknik |
SyntheticMR is thrilled to announce the appointment of Dr. Jeff Miller to their Medical Advisory Board.
Dr. Miller is the Chief of Radiology and a Pediatric Neuroradiologist at Phoenix Children's Hospital in Arizona. He completed his Diagnostic Radiology residency training at St. Louis University School of Medicine and a fellowship in Diagnostic Neuroradiology at the Mallinckrodt Institute of Radiology. In addition to his duties at Phoenix Children's, he is a Clinical Assistant Professor of Radiology at the University of Arizona College of Medicine, Mayo Clinic Scottsdale, and the Barrow Neurological Institute.
Dr. Miller is a member of the American Society of Neuroradiology (ASNR), the International Society of Magnetic Resonance in Medicine (ISMRM), and the American Society of Pediatric Neuroradiology (ASPNR). Additionally, he is a member of the Industry Relations and Research Award Committees of the American Society of Pediatric Neuroradiology. He was awarded to the Best Doctors database in 2010 and received the ASPNR Pediatric Neuroradiology Research Grant Award in 2007.
"I am very excited to join SyntheticMR's medical advisory board," says Dr. Miller. "I am looking forward to working with their team on developing and further refining quantitative MRI applications within pediatrics."
As a Medical Advisory Board member, Dr. Miller will help guide SyntheticMR's product management and strategic initiatives using his extensive experience within clinical and academic radiology as well as pediatrics and neuroradiology.
"As a rapidly growing global company, our feedback from our users is essential to our success," says Kyle Frye, President & CCO at SyntheticMR. "Dr. Miller's expert advice will be critical to our innovation as we seek to support a faster and more reliable diagnosis of patients worldwide."
"We work closely with our customers to ensure our product fit their needs and adds true clinical value," says Ulrik Harrysson, CEO SyntheticMR. "Dr Miller's input will be extremely valuable to us as we continue to set a new standard of care within pediatric neuroimaging."
For additional information, please contact Ulrik Harrysson, CEO, SyntheticMR AB, +46 70 529 29 87 ulrik.harrysson@syntheticmr.com or KyleFrye, President SyntheticMR Inc. at +1 (859) 512-9496 or kyle.frye@syntheticmr.com.